Detalles de la búsqueda
1.
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.
Br J Haematol
; 202(4): 749-759, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36257914
2.
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study.
Haematologica
; 108(3): 822-832, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36263843
3.
Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma.
Future Oncol
; 19(22): 1535-1547, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37578377
4.
Patient preferences for treatment in relapsed/refractory diffuse large B-cell lymphoma: a discrete choice experiment.
Future Oncol
; 18(25): 2791-2804, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35837970
5.
Unintended Consequences Following the 2014 American Academy of Pediatrics Policy Change for Palivizumab Prophylaxis among Infants Born at Less than 29 Weeks' Gestation.
Am J Perinatol
; 38(S 01): e201-e206, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32299107
6.
Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.
BMC Cancer
; 18(1): 44, 2018 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29306325
7.
The 2014-2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States.
Am J Perinatol
; 35(2): 192-200, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28881376
8.
Respiratory Syncytial Virus Hospitalizations among U.S. Preterm Infants Compared with Term Infants Before and After the 2014 American Academy of Pediatrics Guidance on Immunoprophylaxis: 2012-2016.
Am J Perinatol
; 35(14): 1433-1442, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29920638
9.
The incidence of bone metastasis after early-stage breast cancer in Canada.
Breast Cancer Res Treat
; 156(3): 587-595, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27083181
10.
Angina and associated healthcare costs following percutaneous coronary intervention: A real-world analysis from a multi-payer database.
Catheter Cardiovasc Interv
; 88(7): 1017-1024, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26774951
11.
Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United States.
Breast Cancer Res Treat
; 146(3): 637-46, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25053278
12.
Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis.
BMC Pediatr
; 14: 261, 2014 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-25308481
13.
Hospital healthcare resource utilization and costs for chimeric antigen T-cell therapy and autologous hematopoietic cell transplant in patients with large B-cell lymphoma in the United States.
Leuk Lymphoma
; : 1-10, 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38567630
14.
Impact of formulary-related pharmacy claim rejections of cariprazine on health care utilization and treatment patterns among patients with bipolar I disorder.
J Manag Care Spec Pharm
; 30(2): 118-128, 2024 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38308622
15.
Network meta-analysis of CAR T-Cell therapy for the treatment of 3L+ R/R LBCL after using published comparative studies.
Expert Rev Anticancer Ther
; : 1-9, 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38646700
16.
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor.
Adv Ther
; 41(5): 1938-1952, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38494543
17.
Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma.
Leuk Lymphoma
; 65(1): 14-25, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37840282
18.
Opioid utilization patterns in United States individuals with sickle cell disease.
Am J Hematol
; 93(10): E345-E347, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30051929
19.
Matching-Adjusted Indirect Comparisons of Brexucabtagene Autoleucel with Alternative Standard Therapies for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients.
Adv Ther
; 40(12): 5383-5398, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801234
20.
A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma.
Expert Rev Anticancer Ther
; 23(2): 199-206, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36723678